Publication: How antimalarial drug resistance affects post-treatment prophylaxis
Issued Date
2008-03-07
Resource Type
ISSN
14752875
Other identifier(s)
2-s2.0-40149110041
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Malaria Journal. Vol.7, (2008)
Suggested Citation
Nicholas J. White How antimalarial drug resistance affects post-treatment prophylaxis. Malaria Journal. Vol.7, (2008). doi:10.1186/1475-2875-7-9 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/19357
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
How antimalarial drug resistance affects post-treatment prophylaxis
Author(s)
Other Contributor(s)
Abstract
Slowly eliminated antimalarial drugs suppress malaria reinfections for a period of time determined by the dose, the pharmacokinetic properties of the drug, and the susceptibility of the infecting parasites. This effect is called post-treatment prophylaxis (PTP). The clinical benefits of preventing recrudescence (reflecting treatment efficacy) compared with preventing reinfection (reflecting PTP) need further assessment. Antimalarial drug resistance shortens PTP. While blood concentrations are in the terminal elimination phase, the degree of shortening may be estimated from measurements of in-vitro susceptibility and the terminal elimination half-life. More information is needed on PTP following intermittent preventive treatments, and on the relationship between the duration of PTP and immunity, so that policy recommendations can have a firmer evidence base. © 2008 White; licensee BioMed Central Ltd.